Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset.
暂无分享,去创建一个
S. Wiegand | H. Fraser | S. Hillier | H. Wilson | P. Taylor
[1] H. Fraser,et al. Expression of anti-Mullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor. , 2007, Endocrinology.
[2] S. Wiegand,et al. Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. , 2006, Reproduction.
[3] S. Wiegand,et al. Single injections of vascular endothelial growth factor trap block ovulation in the macaque and produce a prolonged, dose-related suppression of ovarian function. , 2005, The Journal of clinical endocrinology and metabolism.
[4] H. Fraser,et al. Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary. , 2004, The Journal of endocrinology.
[5] J. Petrik,et al. Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. , 2004, Endocrinology.
[6] M. Bagheri,et al. Ovarian stromal blood flow changes after laparoscopic ovarian cauterization in women with polycystic ovary syndrome. , 2003, Human reproduction.
[7] C. Simón,et al. Administration of Moderate and High Doses of Gonadotropins to Female Rats Increases Ovarian Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor-2 Expression that Is Associated to Vascular Hyperpermeability1 , 2003, Biology of reproduction.
[8] P. Bohlen,et al. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. , 2003, The Journal of clinical investigation.
[9] G. Conway,et al. Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. , 2002, Fertility and sterility.
[10] C. Simón,et al. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. , 2002, Endocrinology.
[11] S. Harper,et al. Regulation of vascular permeability by vascular endothelial growth factors. , 2002, Vascular pharmacology.
[12] G. Yancopoulos,et al. VEGF-Trap: A VEGF blocker with potent antitumor effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Clemens,et al. Water permeability of an ovarian antral follicle is predominantly transcellular and mediated by aquaporins. , 2002, Endocrinology.
[14] S. Wiegand,et al. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. , 2002, Endocrinology.
[15] S. Franks,et al. Developmental origin of polycystic ovary syndrome - a hypothesis. , 2002, The Journal of endocrinology.
[16] P. Bohlen,et al. Administration of antivascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey. , 2002, Endocrinology.
[17] Y. Soong,et al. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. , 2002, The Journal of clinical endocrinology and metabolism.
[18] K. Alitalo,et al. Vascular growth factors and lymphangiogenesis. , 2002, Physiological reviews.
[19] M. Wu,et al. Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis. , 2002, Human reproduction.
[20] S. Wiegand,et al. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). , 2001, The Journal of clinical endocrinology and metabolism.
[21] S. Wiegand,et al. Angiogenesis During Follicular Development in the Primate and its Inhibition by Treatment with Truncated Flt-1-Fc (Vascular Endothelial Growth Factor TrapA40). , 2001, Endocrinology.
[22] M. Sauer,et al. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. , 2001, The Journal of clinical endocrinology and metabolism.
[23] R. Gilchrist,et al. Changes in Follicle-Stimulating Hormone and Follicle Populations During the Ovarian Cycle of the Common Marmoset1 , 2001, Biology of reproduction.
[24] H. Fraser,et al. The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate. , 1999, Human reproduction.
[25] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[26] R. Koos. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. , 1995, Biology of reproduction.
[27] G. Palade,et al. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.
[28] R. Hunter,et al. Physiological factors underlying the formation of ovarian follicular fluid. , 1988, Journal of reproduction and fertility.
[29] J. Hodges,et al. Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus). , 1985, Journal of reproduction and fertility.
[30] J. Hodges,et al. Ovulation in the marmoset monkey: endocrinology, prediction and detection. , 1984, The Journal of endocrinology.